You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Inflammatory Breast Neoplasms

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Inflammatory Breast Cancer Trial (Breast conserving surgery, Radical modified mastectomy)

Not yet recruiting
  • Inflammatory Breast Cancer
  • Breast conserving surgery
  • Radical modified mastectomy
  • (no location specified)
Nov 14, 2023

Breast Cancer, Inflammatory Breast Cancer Stage IV, Inflammatory Breast Tumors Trial in Knoxville (Self-Administered Hypnosis,

Recruiting
  • Breast Cancer
  • +4 more
  • Self-Administered Hypnosis
  • Self-Administered White Noise Hypnosis
  • Knoxville, Tennessee
    University of Tennessee Knoxville
Sep 26, 2023

Invasive Breast Cancer, Inflammatory Breast Cancer Stage III, HER2-positive Breast Cancer Trial in Boston (Trastuzumab

Not yet recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +1 more
Mar 20, 2023

Inflammatory Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Boston (Eribulin, Adriamycin,

Active, not recruiting
Has Results
  • Inflammatory Breast Cancer
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Boston, Massachusetts
  • +1 more
Nov 28, 2022

Tumor Biopsy in Creating Research Tissue Registry in

Recruiting
  • Inflammatory Breast Carcinoma
  • +2 more
  • Biospecimen Collection
  • +3 more
  • Houston, Texas
  • +4 more
Jan 6, 2023

Edema, Erythema, Estrogen Receptor Negative Trial in Houston (Laboratory Biomarker Analysis, Pembrolizumab)

Active, not recruiting
  • Edema
  • +8 more
  • Laboratory Biomarker Analysis
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Jan 23, 2023

Breast Cancer, HER2-positive Breast Cancer, Triple Negative Breast Cancer Trial in Boston (MRI)

Recruiting
  • Breast Cancer
  • +5 more
  • MRI
  • Boston, Massachusetts
    Brigham and Women's Hospital
Dec 9, 2022

Breast Cancer Trial in Houston (Panitumumab, Nab-paclitaxel, Carboplatin)

Completed
Has Results
  • Breast Cancer
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 20, 2022

Breast Inflammatory Carcinoma, Recurrent Breast Inflammatory Carcinoma, Stage IV Breast Inflammatory Carcinoma Trial in Houston

Recruiting
  • Breast Inflammatory Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 27, 2022

Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Breast Inflammatory Carcinoma Trial in

Active, not recruiting
  • Anatomic Stage IIIB Breast Cancer AJCC v8
  • +4 more
  • Pembrolizumab
  • Houston, Texas
    M D Anderson Cancer Center
Sep 30, 2022

Breast Cancer, Invasive Breast Cancer, Unresectable Breast Carcinoma Trial in Boston (Onvansertib, Paclitaxel)

Recruiting
  • Breast Cancer
  • +9 more
  • Boston, Massachusetts
  • +2 more
Oct 25, 2022

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

Breast Cancer Trial (Gemcitabine, Epirubicin, Docetaxel)

Completed
Has Results
  • Breast Cancer
  • (no location specified)
Oct 4, 2021

Breast Cancer Trial in Bloomington, New York (Nivolumab 360mg, Paclitaxel 80mg/m^2, Doxorubicin 60mg/m^2)

Completed
Has Results
  • Breast Cancer
  • Nivolumab 360mg
  • +6 more
  • Bloomington, Indiana
  • +1 more
Feb 2, 2022

Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8

Active, not recruiting
  • Anatomic Stage IIB Breast Cancer AJCC v8
  • +19 more
  • Gilbert, Arizona
  • +4 more
Dec 6, 2022

Inflammatory Breast Cancer, Invasive Ductal Breast Carcinoma, Invasive Lobular Breast Carcinoma Trial in New Brunswick, Salt

Active, not recruiting
  • Inflammatory Breast Cancer
  • +9 more
  • External beam radiation therapy
  • New Brunswick, New Jersey
  • +1 more
Jan 30, 2022

Breast Cancer Patients Receiving Neoadjuvant Chemotherapy

Not yet recruiting
  • Breast Cancer
    • (no location specified)
    Jul 18, 2022

    Individual Radiosensitivity During Radiotherapy for Breast

    Recruiting
    • Radiation Tolerance
    • Breast Neoplasms
    • Blood sample
    • Stockholm, Sweden
      Karolinska University Hospital
    Oct 2, 2022

    Anatomic Stage IV Breast Cancer AJCC v8, Breast Inflammatory Carcinoma, Metastatic Triple-Negative Breast Carcinoma Trial in

    Not yet recruiting
    • Anatomic Stage IV Breast Cancer AJCC v8
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Oct 13, 2021

    Locally Advanced Malignant Tumor, Inflammatory Breast Carcinoma, Triple-Negative Invasive Breast Carcinoma Trial in Amsterdam

    Completed
    • Locally Advanced Malignant Neoplasm
    • +2 more
    • Amsterdam, Netherlands
      The Netherlands Cancer Institute
    Aug 3, 2021

    Cancer, Treatment-Related, Tumor of Breast, Systemic Inflammatory Response Trial in Roma (cryoablation)

    Completed
    • Cancer, Treatment-Related
    • +3 more
    • cryoablation
    • Roma, Italy
      Sapienza University of Rome
    Feb 13, 2023

    HER2-positive Breast Cancer, Recurrent Breast Cancer, Stage IIA Breast Cancer Trial in Duarte, Lancaster, South Pasadena

    Active, not recruiting
    • HER2-positive Breast Cancer
    • +9 more
    • pertuzumab
    • +3 more
    • Duarte, California
    • +2 more
    Mar 17, 2022

    Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8

    Recruiting
    • Anatomic Stage III Breast Cancer AJCC v8
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jun 16, 2022

    Breast Cancer Trial in Taichung (Diclofenac)

    Completed
    • Breast Cancer
    • Taichung, Taiwan
      China Medical University Hospital
    Jul 18, 2022

    Breast Cancer Trial in Toronto

    Recruiting
    • Breast Cancer
      • Toronto, Ontario, Canada
        Sunnybrook Health Sciences Centre-Odette Cancer Centre
      Jan 10, 2023